Patrawala et al (2006) recently showed that CD44+ cells derived from prostate cell lines are enriched in tumour progenitor cells, and Collins et al (2005) have demonstrated that CD44+α2β1hiCD133+ cells from patients are highly tumorigenic. The gene discussed is CD44; the disease is neoplasm.